Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Company Is First To Announce Positive Results, With Only One Other Confirmed Study
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
